Gain Therapeutics (GANX)
(Delayed Data from NSDQ)
$2.96 USD
+0.03 (1.02%)
Updated May 3, 2024 04:00 PM ET
After-Market: $2.96 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/10/2024
Time: -- |
3/2024 | $-0.30 | -5.08% |
Earnings Summary
For their last quarter, Gain Therapeutics (GANX) reported earnings of -$0.29 per share, beating the Zacks Consensus Estimate of $-0.32 per share. This reflects a positive earnings surprise of 9.38%. Look out for GANX's next earnings release expected on May 10, 2024. For the next earning release, we expect the company to report earnings of -$0.30 per share, reflecting a year-over-year increase of 30.23%.
Earnings History
Price & Consensus
Zacks News for GANX
Here's Why Gain Therapeutics (GANX) Could be Great Choice for a Bottom Fisher
GANX: What are Zacks experts saying now?
Zacks Private Portfolio Services